Genetic Epidemiological Study of Lung Cancer in Taiwan and Clinical Applications
Genetic Epidemiological Study of Lung Cancer in Taiwan and Clinical Applications-focusing on Female Lung Adenocarcinoma (GEFLAC)
Sponsor: Chang Gung Memorial Hospital
This observational or N/A phase trial investigates Lung Cancer and is currently ongoing. Chang Gung Memorial Hospital leads this study, which shows 7 recorded versions since 2002 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Unknown
-
Sep 2024 — Sep 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status
▶ Show 2 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Unknown Status
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Unknown Status NA
First recorded
May 2002
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Chang Gung Memorial Hospital
- Kaohsiung Medical University
- National Cheng-Kung University Hospital
- National Health Research Institutes, Taiwan
- National Taiwan University Hospital
- Taichung Veterans General Hospital
- Taipei Veterans General Hospital, Taiwan
For direct contact, visit the study record on ClinicalTrials.gov .